C57BL/6JCya-Adgre1em1flox/Cya
Common Name
Adgre1-flox
Product ID
S-CKO-02196
Backgroud
C57BL/6JCya
Strain ID
CKOCMP-13733-Adgre1-B6J-VA
When using this mouse strain in a publication, please cite “Adgre1-flox Mouse (Catalog S-CKO-02196) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Adgre1-flox
Strain ID
CKOCMP-13733-Adgre1-B6J-VA
Gene Name
Product ID
S-CKO-02196
Gene Alias
Emr1, Ly71, F4/80, Gpf480, TM7LN3, DD7A5-7, EGF-TM7
Background
C57BL/6JCya
NCBI ID
Modification
Conditional knockout
Chromosome
Chr 17
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000086763
NCBI RefSeq
NM_010130
Target Region
Exon 10
Size of Effective Region
~0.8 kb
Overview of Gene Research
Adgre1, also known as EMR1 and F4/80, is an adhesion G protein-coupled receptor. It is widely used as a monocyte-macrophage marker in mice. ADGRE1 contains repeated Epidermal Growth Factor (EGF)-like calcium-binding domains in its extracellular domain. Its expression is induced by macrophage colony-stimulating factor (CSF1) treatment in vivo, and it may play a role in pathogen recognition due to its rapid evolution [1,2].
In colon cancer, tumor-associated macrophages (TAMs) can upregulate EMR1 (ADGRE1) in cancer cells. This upregulation promotes colon cancer progression by activating the JAK2/STAT1,3 signaling pathway, increasing cell proliferation, migration, and motility, and reducing apoptosis. Inhibition of JAK2/STAT3 can significantly impede the proliferation, migration, and mobility of cells and increase the apoptosis of EMR1+ colon cancer cells. Also, EMR1 expression in colon cancer cells is related to M2 macrophage polarization, and CRC with a high combined EMR1-TC+CD68+CD163+ score shows a worse recurrence-free survival prognosis [3,4].
In conclusion, Adgre1 is a key marker for monocyte-macrophages with potential roles in pathogen recognition. In colon cancer, the upregulation of Adgre1 by TAMs is involved in cancer progression through the JAK2/STAT1,3 signaling pathway, highlighting its significance in understanding colon cancer development and potentially providing new therapeutic targets.
References：
1. Hamann, Jörg, Aust, Gabriela, Araç, Demet, Langenhan, Tobias, Schiöth, Helgi B. . International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. In Pharmacological reviews, 67, 338-67. doi:10.1124/pr.114.009647. https://pubmed.ncbi.nlm.nih.gov/25713288/
2. Waddell, Lindsey A, Lefevre, Lucas, Bush, Stephen J, Hope, Jayne C, Hume, David A. 2018. ADGRE1 (EMR1, F4/80) Is a Rapidly-Evolving Gene Expressed in Mammalian Monocyte-Macrophages. In Frontiers in immunology, 9, 2246. doi:10.3389/fimmu.2018.02246. https://pubmed.ncbi.nlm.nih.gov/30327653/
3. Akter, Rokeya, Park, Rackhyun, Lee, Soo Kyung, Park, Junsoo, Cho, Mee-Yon. 2024. Upregulation of EMR1 (ADGRE1) by Tumor-Associated Macrophages Promotes Colon Cancer Progression by Activating the JAK2/STAT1,3 Signaling Pathway in Tumor Cells. In International journal of molecular sciences, 25, . doi:10.3390/ijms25084388. https://pubmed.ncbi.nlm.nih.gov/38673975/
4. Akter, Rokeya, Kim, Kwangmin, Kwon, Hye Youn, Cho, Hye-Mi, Cho, Mee-Yon. 2022. EMR1/ADGRE1 Expression in Cancer Cells Upregulated by Tumor-Associated Macrophages Is Related to Poor Prognosis in Colorectal Cancer. In Biomedicines, 10, . doi:10.3390/biomedicines10123121. https://pubmed.ncbi.nlm.nih.gov/36551877/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.